Morgan M Y, Milsom J P, Sherlock S
Gut. 1978 Nov;19(11):1068-73. doi: 10.1136/gut.19.11.1068.
The molar ratio valine + leucine + isoleucine/phenylalanine + tyrosine was determined in the plasma of patients with liver disease of varying aetiology and severity and in an age and sex matched control group. In the control group of 58 subjects the mean ratio was 3.3 +/- 0.5 (ISD). The mean ratio was significantly lowered in groups of 25 patients with alcoholic cirrhosis (P less than 0.001), 25 patients with chronic active hepatitis (P less than 0.001), 23 patients with primary biliary cirrhosis (P less than 0.001), and 11 patients with cryptogenic cirrhosis (P less than 0.001). In a group of 50 patients with cirrhosis, the ratio was significantly lowered (P less than 0.001) irrespective of the presence of hepatic encephalopathy. A good correlation existed between the value of the ratio and the severity of the liver disease as judged histologically, with values of the ratio appearing to reflect histological change irrespective of the patient's clinical condition. There was no significant diurnal variation in the value of the ratio. Lowering of this plasma amino acid ratio appears to be secondary to liver disease and quite independent of the presence of hepatic encephalopathy.
测定了不同病因和严重程度的肝病患者以及年龄和性别匹配的对照组血浆中缬氨酸+亮氨酸+异亮氨酸/苯丙氨酸+酪氨酸的摩尔比。在58名受试者的对照组中,平均比值为3.3±0.5(标准差)。在25例酒精性肝硬化患者组(P<0.001)、25例慢性活动性肝炎患者组(P<0.001)、23例原发性胆汁性肝硬化患者组(P<0.001)和11例隐源性肝硬化患者组(P<0.001)中,平均比值显著降低。在50例肝硬化患者组中,无论是否存在肝性脑病,该比值均显著降低(P<0.001)。根据组织学判断,该比值与肝病严重程度之间存在良好的相关性,比值似乎反映了组织学变化,而与患者的临床状况无关。该比值没有明显的昼夜变化。这种血浆氨基酸比值的降低似乎继发于肝病,且与肝性脑病的存在无关。